In this study, we used sodium chloride (NaCl) to extensively modulate non-specific protein-protein interactions (PPI) of a humanized anti-streptavidin monoclonal antibody class 2 molecule (ASA-IgG2). The changes in PPI with varying NaCl (CNaCl) and monoclonal antibody (mAb) concentration (CmAb) were assessed using the diffusion interaction parameter kD and second virial coefficient B22 measured from solutions with low to moderate CmAb. The effective structure factor S(q)eff measured from concentrated mAb solutions using small-angle X-ray and neutron scattering (SAXS/SANS) was also used to characterize the PPI. Our results found that the nature of net PPI changed not only with CNaCl, but also with increasing CmAb. As a result, parameters mea...
AbstractSome monoclonal antibodies (mAbs) are reported to display concentration-dependent reversible...
To separate proteins solely based on their difference in hydrodynamic volume in size exclusion chro-...
For biotechnological drugs, it is desirable to formulate antibody solutions with low viscosities. We...
Solutions of monoclonal antibodies (mAbs) at high concentration are strongly desirable for subcutane...
The ability to design and formulate mAbs to minimize attractive interactions at high concentrations ...
The purpose of this work was to elucidate the molecular interactions leading to monoclonal antibody ...
AbstractSmall-angle neutron scattering (SANS) is used to probe the solution structure of two protein...
High concentration subcutaneous (SC) dosing regimens are desirable for monoclonal antibody (MAb) the...
AbstractWeak protein-protein interactions are thought to modulate the viscoelastic properties of con...
High protein titers are gaining importance in biopharmaceutical industry. A major challenge in the d...
The solution thermodynamics and interactions of a reversibly self-associating IgG1 monoclonal antibo...
Roberts, Christopher J.Monoclonal antibodies (mAbs) are one of the leading protein-based drug candid...
We investigated the influence of pH and sodium chloride concentration on aggregation kinetics of a m...
AbstractLiquid-liquid phase separation was studied for a monoclonal antibody in the monovalent salt ...
The aggregation propensity of monoclonal antibodies can be modified by adding different cosolutes in...
AbstractSome monoclonal antibodies (mAbs) are reported to display concentration-dependent reversible...
To separate proteins solely based on their difference in hydrodynamic volume in size exclusion chro-...
For biotechnological drugs, it is desirable to formulate antibody solutions with low viscosities. We...
Solutions of monoclonal antibodies (mAbs) at high concentration are strongly desirable for subcutane...
The ability to design and formulate mAbs to minimize attractive interactions at high concentrations ...
The purpose of this work was to elucidate the molecular interactions leading to monoclonal antibody ...
AbstractSmall-angle neutron scattering (SANS) is used to probe the solution structure of two protein...
High concentration subcutaneous (SC) dosing regimens are desirable for monoclonal antibody (MAb) the...
AbstractWeak protein-protein interactions are thought to modulate the viscoelastic properties of con...
High protein titers are gaining importance in biopharmaceutical industry. A major challenge in the d...
The solution thermodynamics and interactions of a reversibly self-associating IgG1 monoclonal antibo...
Roberts, Christopher J.Monoclonal antibodies (mAbs) are one of the leading protein-based drug candid...
We investigated the influence of pH and sodium chloride concentration on aggregation kinetics of a m...
AbstractLiquid-liquid phase separation was studied for a monoclonal antibody in the monovalent salt ...
The aggregation propensity of monoclonal antibodies can be modified by adding different cosolutes in...
AbstractSome monoclonal antibodies (mAbs) are reported to display concentration-dependent reversible...
To separate proteins solely based on their difference in hydrodynamic volume in size exclusion chro-...
For biotechnological drugs, it is desirable to formulate antibody solutions with low viscosities. We...